Novartis under fire from Tasigna allegations

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 14 May, 2014

Singapore: Swiss giant Novartis Pharma's Japanese arm has prompted the Japanese health ministry to launch an investigation under possible violation of the pharmaceutical affairs law. It has...Read more

Genmab in research deal with Kyowa Hakko Kirin

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 07 Dec, 2012

Singapore: Genmab has entered into a research collaboration with Japan-based Kyowa Hakko Kirin to create bispecific antibodies using Genmab's DuoBody technology. If successful, the parties ...Read more

Japanese-Thai program to fund three projects

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 27 Jul, 2012

Singapore: Japan Science and Technology Agency (JST) and the National Science and Technology Development Agency (NSTDA) have developed a scheme for joint funding of Japanese-Thai cooperativ...Read more

Daiichi seeks approval for influenza antiviral in Japan

Japan |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 19 Nov, 2012

Singapore: Daiichi Sankyo has submitted an application for a partial label change in Japan to manufacture and market the influenza antiviral product Inavir Dry Powder Inhaler (laninamivir o...Read more

Mitsubishi and Daiichi Sankyo to launch diabetes drug in Japan

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 28 Aug, 2012

Singapore: Mitsubishi Tanabe Pharma and Daiichi Sankyo will launch selective DPP-4 inhibitor Tenelia 20mg tablets (teneligliptin hydrobromide hydrate tablets) in Japan on September 10, 2012...Read more

Pic Gallery - 7th in-Pharma Japan and 26th Interphex Japan

Japan |  Analysis | By BioSpectrum Bureau  | 0 Comment | 05 Aug, 2013

7th in-Pharma Japan and 26th Interphex Japan, which was held from July 10-12, 2013, at Tokyo Big Sight, Japan...Read more

Pharma companies focus on supply chain in Japan

Japan |  Analysis | By BioSpectrum Bureau  | 0 Comment | 19 Jul, 2012

Singapore: Pressures felt in Japan as a result of the country's aging population, drug price revisions and patent expiries have compelled pharmaceutical industry leaders to rationalize thei...Read more

Takeda subsidiary suspended for 'no drug label'

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 20 Feb, 2013

Singapore: Takeda Pharmaceutical received an Order for Corrective Action regarding the manufacturing and marketing of Alinamin-F5 Injection from the Osaka Prefectural Government, citing a v...Read more

Thermo Fisher enters into agreement Fujirebio

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 21 Nov, 2012

Singapore: Thermo Fisher Scientific signed a long-term license agreement with Fujirebio to make its biomarker assay Procalcitonin (PCT) available on the Lumipulse family of laboratory ins...Read more

Bayer colorectal cancer drug gets Japanese nod

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 26 Mar, 2013

Singapore: Japan's Ministry of Health, Labor and Welfare (MHLW) has approved Bayer HealthCare and Onyx Pharmaceuticals's Stivarga (regorafenib) tablets for the treatment of patients with me...Read more

Astellas, Ambit terminate cancer drug deal

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 12 Mar, 2013

Singapore: Japan-based Astellas Pharma and US-headquartered Ambit Biosciences are ending their collaboration for joint development and commercialization of FMS-like tyrosine kinase-3 (FLT3)...Read more

Edison Pharma, DSP enter $4 bn metablosim drug deal

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 04 Feb, 2014

Singapore: US-based Edison Pharmaceuticals has entered into a strategic alliance valued up to $4.295 billion with Japan's Dainippon Sumitomo Pharma (DSP) for the development of drugs target...Read more

Gilead files NDA for Hep C drug in Japan

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 30 Jun, 2014

Singapore: US-based Gilead Sciences has submitted a New Drug Application (NDA) to Japan's Pharmaceutical and Medical Devices Agency (PMDA) for approval of sofosbuvir, a once-daily nucleotid...Read more

AnGes, Mitsubishi Tanabe sign MoU to market Collategene

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 29 Oct, 2012

Singapore: AnGes MG entered into a definitive agreement with Mitsubishi Tanabe Pharma for the exclusive marketing rights of Collategene (DNA plasmid with HGF gene) as a treatment for peri...Read more

What the future holds for the APAC CRO market?

Japan |  Analysis | By BioSpectrum Bureau  | 0 Comment | 18 Sep, 2013

The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conducted in association with CyberMedia Research (CMR), yet again identifie...Read more

Japan scientists pioneer new stem cell technology

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 24 Jul, 2012

Singapore: A research team at the tissue regeneration materials unit, National Institute for Materials Science (NIMS), succeeded in fabricating two types of cell matrix materials that mimic...Read more

Astellas gets FDA nod for kidney transplant drug

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 22 Jul, 2013

Singapore: Japan-based Astellas Pharma has received US FDA approval for Astagraf XL (tacrolimus extended-release capsules) for the prophylaxis of organ rejection in patients receiving a kid...Read more

Global collaborations is the way forward for drug discovery

Japan |  Analysis | By BioSpectrum Bureau  | 0 Comment | 19 Dec, 2012

Over the last few decades India has reiterated its capabilities in providing dependable and cost effective chemistry services to big pharma through a multitude of outsourcing deals. A large...Read more